Pancreatic Cancer
Showing NaN - NaN of 80
Longitudinal Pancreatic Cancer Study
Completed
- Pancreatic Cancer
- CA 19-9 Assay
-
Boca Raton, Florida
- +6 more
Aug 16, 2021
Metastatic Pancreatic Cancer, Pancreatic Cancer Trial in Worldwide (IMMU-107, , Gemcitabine)
Terminated
- Metastatic Pancreatic Cancer
- Pancreatic Cancer
- IMMU-107
- +2 more
-
Gilbert, Arizona
- +64 more
Aug 12, 2021
Pancreatic Cancer Trial in Baltimore (Gemcitabine, Taxotere, Xeloda)
Completed
- Pancreatic Cancer
- Gemcitabine
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 29, 2021
Pancreatic Cancer Trial in Worldwide (Registry)
Active, not recruiting
- Pancreatic Cancer
- Registry
-
Birmingham, Alabama
- +15 more
Apr 8, 2021
Pancreatic Cancer Trial in San Francisco, Baltimore (S-1, gemcitabine HCl)
Terminated
- Pancreatic Cancer
- S-1
- gemcitabine hydrochloride
-
San Francisco, California
- +1 more
Aug 28, 2020
Breast Cancer, Prostate Cancer, Lung Cancer Trial in Baltimore (Metformin, Coach Directed Behavioral Weight Loss, Self-control
Completed
- Breast Cancer
- +10 more
- Metformin
- +2 more
-
Baltimore, MarylandJohns Hopkins ProHealth
Aug 26, 2020
Pancreatic Cancer Trial in Baltimore (erlotinib HCl)
Completed
- Pancreatic Cancer
- erlotinib hydrochloride
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
May 18, 2020
Pancreatic Cancer Trial in United States (biological, drug, radiation)
Completed
- Pancreatic Cancer
- HyperAcute-Pancreas Immunotherapy
- +2 more
-
Birmingham, Alabama
- +74 more
May 26, 2020
Pancreatic Cancer Trial in Worldwide (erlotinib HCl, gemcitabine HCl)
Completed
- Pancreatic Cancer
- erlotinib hydrochloride
- gemcitabine hydrochloride
-
Tucson, Arizona
- +172 more
Mar 31, 2020
Pancreatic Cancer Trial in Baltimore (GVAX pancreatic cancer vaccine, cyclophosphamide)
Completed
- Pancreatic Cancer
- GVAX pancreatic cancer vaccine
- cyclophosphamide
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 12, 2020
Pancreatic Cancer Trial in Baltimore (Ipilimumab, Pancreatic Cancer Vaccine)
Completed
- Pancreatic Cancer
- Ipilimumab
- Pancreatic Cancer Vaccine
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 20, 2020
Pancreatic Cancer Trial in Baltimore (Cetuximab, Pancreatic tumor vaccine, Cyclophosphamide)
Completed
- Pancreatic Cancer
- Cetuximab
- +2 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 10, 2020
Bladder Cancer, Breast Cancer, Colorectal Cancer Trial in Baltimore, Bethesda (LMB-9 immunotoxin)
Completed
- Bladder Cancer
- +5 more
- LMB-9 immunotoxin
-
Baltimore, Maryland
- +1 more
Oct 31, 2019
Pancreatic Cancer Trial in Canada, United States (erlotinib HCl, gemcitabine HCl, therapeutic conventional surgery)
Completed
- Pancreatic Cancer
- erlotinib hydrochloride
- +2 more
-
La Jolla, California
- +23 more
Oct 4, 2019
Surgical Site Infection, Pancreatic Tumors, Pancreatic Cancer Trial in Baltimore (Prevena Peel & Place Dressing, Standard
Completed
- Surgical Site Infection
- +6 more
- Prevena Peel & Place Dressing
- Standard Closure of the Surgical Incision
-
Baltimore, MarylandJohns Hopkins Hospital
Aug 13, 2019
Solid Tumors, Pancreatic Cancer Trial in United States (itacitinib, Gemcitabine, nab-paclitaxel)
Completed
- Solid Tumors
- Pancreatic Cancer
- itacitinib
- +3 more
-
Scottsdale, Arizona
- +7 more
Jul 16, 2019
Pancreatic Cancer Trial in Worldwide (Ruxolitinib, Placebo, Capecitabine)
Colorectal Cancer, Pancreatic Cancer, Psychosocial Effects of Cancer and Its Treatment Trial in Baltimore (counseling
Completed
- Colorectal Cancer
- +2 more
- counseling intervention
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 19, 2019
Neoplastic Cells, Circulating, Pancreatic Cancer, Biological Markers Trial in Baltimore (No intervention/exposures)
Completed
- Neoplastic Cells, Circulating
- +2 more
- No intervention/exposures
-
Baltimore, MarylandJohns Hopkins University
Jan 22, 2019
Pancreatic Cancer Trial in Baltimore (Radiolabeled humanized PAM4 IgG)
Terminated
- Pancreatic Cancer
- Radiolabeled humanized PAM4 IgG
-
Baltimore, MarylandJohns Hopkins Institution, Dept of Radiology and Radiological Sc
Jan 16, 2019
Pancreatic Cancer Trial in Baltimore (biological, drug, procedure)
Terminated
- Pancreatic Cancer
- cetuximab
- +8 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Oct 22, 2018
Amyotrophic Lateral Sclerosis, GI Cancer, Pancreatic Cancer Trial in Baltimore (TAILORED Patient Family Decision Making,
Completed
- Amyotrophic Lateral Sclerosis
- +2 more
- TAILORED Patient Family Decision Making
- standard of care
-
Baltimore, MarylandJohns Hopkins University
Aug 31, 2018
Pancreatic Cancer Trial in Baltimore (Mitomycin-C)
Withdrawn
- Pancreatic Cancer
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jul 10, 2018
Pancreatic Cancer Trial in Worldwide (Ruxolitinib, Placebo, Capecitabine)
Pancreatic Cancer Trial in Worldwide (Tarceva (erlotinib HCl, OSI-774))
Completed
- Pancreatic Cancer
- Tarceva (erlotinib HCl, OSI-774)
-
Tucson, Arizona
- +139 more
Jan 8, 2018